Market Overview:
The global pharma clinical trial services market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising demand for novel therapies, and growing number of clinical trials. The global pharma clinical trial services market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into drug development services, clinical trial products and services, aseptic processing services, professional packaging services, project management services,, and other service types. The drug development segment is expected to account for the largest share of the global pharmaclinical trialservicesmarket in 2018 owing tothe increasing demand for novel therapiesand rising prevalenceof chronic diseases.
Product Definition:
Pharma Clinical Trial Services refers to the various services that are provided by the pharmaceutical industry to support clinical trials. This includes providing drug products and other supplies, managing study sites and patient enrollment, data management and analysis, and reporting. The importance of Pharma Clinical Trial Services is that they help ensure that clinical trials are conducted safely and efficiently, in order to bring new drugs to market as quickly as possible.
Drug Development:
The global drug development industry is expected to grow at a lucrative rate over the forecast period. The growth of this market can be attributed to factors such as increasing prevalence of chronic diseases, rising demand for new drugs and growing investments in R&D by biotechnology and pharmaceutical companies.
Clinical Trial Products:
Clinical trial products are the materials and/or devices used by researchers to test a new drug's safety and efficacy in humans. They are also known as clinical research materials or CRM, which stands for Clinical Research Materials. These products can be divided into two categories- those used during clinical trials that involve human beings (clinical trial phase) and those used after the completion of clinical trials (post-marketing phase).
Application Insights:
The other application segment includes respiratory, gastrointestinal, genitourinary and urological diseases. The growing prevalence of chronic conditions such as cancer, Cardiovascular Diseases (CVDs), diabetes and infectious diseases is anticipated to drive the demand for clinical trials over the forecast period.
Clinical trials for cancer are conducted to evaluate the effectiveness of new drugs on tumor growth or progression or assess their side effects on various organs like liver & kidneys. Increasing government funding towards research in order to improve treatment outcomes is expected to boost industry growth during the forecast period.
The cardiovascular disease segment held around 15% revenue share in 2017 owing to increasing incidence rates coupled with high product penetration in Europe and North America regions. Rising awareness about preventive measures against heart-related disorders coupled with rising geriatric population across countries will further fuel industry expansion over next few years.
Regional Analysis:
Asia Pacific is expected to be the fastest-growing regional market over the forecast period. The growth of this region can be attributed to increasing R&D activities and rising number of clinical trials in emerging countries, such as China and India. In addition, growing healthcare IT infrastructure in these regions is anticipated to fuel the industry expansion during the forecast period.
The Asia Pacific region was followed by North America which accounted for a revenue share of 24% in 2017 owing to high prevalence of chronic diseases that require clinical trials coupled with presence of major trial service providers, such as Covance Inc., within this region. Moreover, government support for conducting clinical trials within this region has increased recently which will further boost industry growth over the next eight years.
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyle and dietary habits of people across the world. As a result, there is an increased demand for effective and safe drugs for the treatment of various chronic diseases. This is expected to drive the growth of the pharma clinical trial services market in the coming years.
- Rising number of clinical trials: A large number of new drug approvals by regulatory authorities such as FDA are resulting in an increase in the number of clinical trials being conducted across different geographies. This is providing immense opportunities for players operating in this market to expand their business operations and cater to rising demand from pharmaceutical companies worldwide.
- Growing focus on outsourcing: There has been a growing trend among pharmaceutical companies to outsource certain phases or entire stagesof their drug development process, including pharma clinical trial services, to specialized service providers in order to reduce costs and improve efficiency .This is expectedto boostthe growth prospectsof thismarketin themonthstocome .
Scope Of The Report
Report Attributes
Report Details
Report Title
Pharma Clinical Trial Services Market Research Report
By Type
Drug Development, Clinical Trial Products, Aseptic Processing, Professional Packaging, Project Management, Other
By Application
Cancer, Cardiovascular Diseases, Central Nervous System, Infectious Disease, Metabolic Disease, Other
By Companies
PCI Pharma Services, Quintiles, Pharmaceutical Product Development (PPD), Parexel International, INC Research Holdings, Pharmaceutical Technology, Clinigen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
148
Number of Tables & Figures
104
Customization Available
Yes, the report can be customized as per your need.
Global Pharma Clinical Trial Services Market Report Segments:
The global Pharma Clinical Trial Services market is segmented on the basis of:
Types
Drug Development, Clinical Trial Products, Aseptic Processing, Professional Packaging, Project Management, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cancer, Cardiovascular Diseases, Central Nervous System, Infectious Disease, Metabolic Disease, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- PCI Pharma Services
- Quintiles
- Pharmaceutical Product Development (PPD)
- Parexel International
- INC Research Holdings
- Pharmaceutical Technology
- Clinigen
Highlights of The Pharma Clinical Trial Services Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Drug Development
- Clinical Trial Products
- Aseptic Processing
- Professional Packaging
- Project Management
- Other
- By Application:
- Cancer
- Cardiovascular Diseases
- Central Nervous System
- Infectious Disease
- Metabolic Disease
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pharma Clinical Trial Services Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pharma Clinical Trial Services (PCTS) is a global clinical trial management company. It provides comprehensive services to support the development and execution of Phase III and IV clinical trials. PCTS' services include: study design, recruitment, monitoring, data management, analysis and reporting; regulatory affairs; contract research organizations (CROs); patient care coordination; safety monitoring; and post-marketing surveillance.
Some of the key players operating in the pharma clinical trial services market are PCI Pharma Services, Quintiles, Pharmaceutical Product Development (PPD), Parexel International, INC Research Holdings, Pharmaceutical Technology, Clinigen.
The pharma clinical trial services market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pharma Clinical Trial Services Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pharma Clinical Trial Services Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pharma Clinical Trial Services Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pharma Clinical Trial Services Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pharma Clinical Trial Services Market Size & Forecast, 2018-2028
4.5.1 Pharma Clinical Trial Services Market Size and Y-o-Y Growth
4.5.2 Pharma Clinical Trial Services Market Absolute $ Opportunity
Chapter 5 Global Pharma Clinical Trial Services Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pharma Clinical Trial Services Market Size Forecast by Type
5.2.1 Drug Development
5.2.2 Clinical Trial Products
5.2.3 Aseptic Processing
5.2.4 Professional Packaging
5.2.5 Project Management
5.2.6 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pharma Clinical Trial Services Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pharma Clinical Trial Services Market Size Forecast by Applications
6.2.1 Cancer
6.2.2 Cardiovascular Diseases
6.2.3 Central Nervous System
6.2.4 Infectious Disease
6.2.5 Metabolic Disease
6.2.6 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pharma Clinical Trial Services Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pharma Clinical Trial Services Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pharma Clinical Trial Services Analysis and Forecast
9.1 Introduction
9.2 North America Pharma Clinical Trial Services Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pharma Clinical Trial Services Market Size Forecast by Type
9.6.1 Drug Development
9.6.2 Clinical Trial Products
9.6.3 Aseptic Processing
9.6.4 Professional Packaging
9.6.5 Project Management
9.6.6 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pharma Clinical Trial Services Market Size Forecast by Applications
9.10.1 Cancer
9.10.2 Cardiovascular Diseases
9.10.3 Central Nervous System
9.10.4 Infectious Disease
9.10.5 Metabolic Disease
9.10.6 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pharma Clinical Trial Services Analysis and Forecast
10.1 Introduction
10.2 Europe Pharma Clinical Trial Services Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pharma Clinical Trial Services Market Size Forecast by Type
10.6.1 Drug Development
10.6.2 Clinical Trial Products
10.6.3 Aseptic Processing
10.6.4 Professional Packaging
10.6.5 Project Management
10.6.6 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pharma Clinical Trial Services Market Size Forecast by Applications
10.10.1 Cancer
10.10.2 Cardiovascular Diseases
10.10.3 Central Nervous System
10.10.4 Infectious Disease
10.10.5 Metabolic Disease
10.10.6 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pharma Clinical Trial Services Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pharma Clinical Trial Services Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pharma Clinical Trial Services Market Size Forecast by Type
11.6.1 Drug Development
11.6.2 Clinical Trial Products
11.6.3 Aseptic Processing
11.6.4 Professional Packaging
11.6.5 Project Management
11.6.6 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pharma Clinical Trial Services Market Size Forecast by Applications
11.10.1 Cancer
11.10.2 Cardiovascular Diseases
11.10.3 Central Nervous System
11.10.4 Infectious Disease
11.10.5 Metabolic Disease
11.10.6 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pharma Clinical Trial Services Analysis and Forecast
12.1 Introduction
12.2 Latin America Pharma Clinical Trial Services Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pharma Clinical Trial Services Market Size Forecast by Type
12.6.1 Drug Development
12.6.2 Clinical Trial Products
12.6.3 Aseptic Processing
12.6.4 Professional Packaging
12.6.5 Project Management
12.6.6 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pharma Clinical Trial Services Market Size Forecast by Applications
12.10.1 Cancer
12.10.2 Cardiovascular Diseases
12.10.3 Central Nervous System
12.10.4 Infectious Disease
12.10.5 Metabolic Disease
12.10.6 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pharma Clinical Trial Services Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pharma Clinical Trial Services Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pharma Clinical Trial Services Market Size Forecast by Type
13.6.1 Drug Development
13.6.2 Clinical Trial Products
13.6.3 Aseptic Processing
13.6.4 Professional Packaging
13.6.5 Project Management
13.6.6 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pharma Clinical Trial Services Market Size Forecast by Applications
13.10.1 Cancer
13.10.2 Cardiovascular Diseases
13.10.3 Central Nervous System
13.10.4 Infectious Disease
13.10.5 Metabolic Disease
13.10.6 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pharma Clinical Trial Services Market: Competitive Dashboard
14.2 Global Pharma Clinical Trial Services Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 PCI Pharma Services
14.3.2 Quintiles
14.3.3 Pharmaceutical Product Development (PPD)
14.3.4 Parexel International
14.3.5 INC Research Holdings
14.3.6 Pharmaceutical Technology
14.3.7 Clinigen
